SCHEMBL30782004

SCHEMBL30782004

NC(=O)N1CC(c2ccccc2)C1

nearest known ligand 0.49

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 5/20 0.49
NPC1 O15118 4/20 0.49
SMN1; SMN2 Q16637 3/20 0.49
ALDH1A1 P00352 3/20 0.49
TP53 P04637 1/20 0.49
POLB P06746 1/20 0.49
SCD O00767 2/20 0.48
SCD5 Q86SK9 2/20 0.48
HDAC2 Q92769 1/20 0.47
MAPT P10636 2/20 0.46
ATM Q13315 1/20 0.46
HPGD P15428 1/20 0.46
GRIN2B Q13224 1/20 0.45
USP30 Q70CQ3 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29554790 0.85 RAB9A (0.63) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
SCHEMBL31323857 0.85 GRIN2B (0.63) HDAC2GRIN2B
SCHEMBL27446535 0.84 ALDH1A1 (0.59) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
SCHEMBL23009741 0.84 ALDH1A1 (0.59) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
SCHEMBL31703460 0.83 RAB9A (0.51) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
SCHEMBL5490962 0.81 KCNH2 (0.56) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
SCHEMBL1790866 0.80 POLB (0.52) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
Hydrochloric Acid SCHEMBL6195871 0.79 KCNH2 (0.55) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
SCHEMBL28511037 0.77 ALDH1A1 (0.54) RAB9ANPC1SMN1; SMN2ALDH1A1TP53
SCHEMBL10264950 0.76 MEN1 (0.60) RAB9ANPC1SMN1; SMN2ALDH1A1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025058459-A1 NOVEL IMIDAZOPYRIDINE-BASED COMPOUND AND COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING, ALLEVIATING, OR TREATING GASTROINTESTINAL INFLAMMATORY DISEASES OR GASTRIC ACID-RELATED DISEASES (주)휴온스 2025-03-20 WO claimed
WO-2025058459-A1 NOVEL IMIDAZOPYRIDINE-BASED COMPOUND AND COMPOSITION COMPRISING SAME AS ACTIVE INGREDIENT FOR PREVENTING, ALLEVIATING, OR TREATING GASTROINTESTINAL INFLAMMATORY DISEASES OR GASTRIC ACID-RELATED DISEASES (주)휴온스 2025-03-20 WO disclosed
CN-117396473-A Imidazopyridinyl inhibitors of plasma kallikrein 武田药品工业株式会社 2024-01-12 CN disclosed